ALGS
Price
$18.63
Change
-$2.22 (-10.65%)
Updated
Feb 21 closing price
Capitalization
66.7M
SEPSF
Price
$0.06
Change
+$0.01 (+20.00%)
Updated
Feb 13 closing price
Capitalization
3.52M
Ad is loading...

ALGS vs SEPSF

Header iconALGS vs SEPSF Comparison
Open Charts ALGS vs SEPSFBanner chart's image
Aligos Therapeutics
Price$18.63
Change-$2.22 (-10.65%)
Volume$339.06K
Capitalization66.7M
ASEP Medical Holdings
Price$0.06
Change+$0.01 (+20.00%)
Volume$10K
Capitalization3.52M
ALGS vs SEPSF Comparison Chart
Loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGS vs. SEPSF commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Hold and SEPSF is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ALGS: $18.63 vs. SEPSF: $0.06)
Brand notoriety: ALGS and SEPSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 100% vs. SEPSF: 141%
Market capitalization -- ALGS: $66.7M vs. SEPSF: $3.51M
ALGS [@Biotechnology] is valued at $66.7M. SEPSF’s [@Biotechnology] market capitalization is $3.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileSEPSF’s FA Score has 1 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • SEPSF’s FA Score: 1 green, 4 red.
According to our system of comparison, SEPSF is a better buy in the long-term than ALGS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 4 TA indicator(s) are bullish.

  • ALGS’s TA Score: 4 bullish, 5 bearish.

Price Growth

ALGS (@Biotechnology) experienced а -21.29% price change this week, while SEPSF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

ALGS is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALGS($66.7M) has a higher market cap than SEPSF($3.52M). SEPSF YTD gains are higher at: 116.606 vs. ALGS (-53.238). SEPSF has higher annual earnings (EBITDA): -4.22M vs. ALGS (-91.86M). ALGS has more cash in the bank: 74.9M vs. SEPSF (12.3K). SEPSF has less debt than ALGS: SEPSF (22.2K) vs ALGS (9.13M). ALGS has higher revenues than SEPSF: ALGS (6M) vs SEPSF (244K).
ALGSSEPSFALGS / SEPSF
Capitalization66.7M3.52M1,893%
EBITDA-91.86M-4.22M2,174%
Gain YTD-53.238116.606-46%
P/E RatioN/AN/A-
Revenue6M244K2,458%
Total Cash74.9M12.3K608,943%
Total Debt9.13M22.2K41,140%
TECHNICAL ANALYSIS
Technical Analysis
ALGS
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AM16.27-0.29
-1.75%
Antero Midstream Corp
TYGO0.96-0.02
-2.12%
Tigo Energy
GSHD106.68-3.47
-3.15%
Goosehead Insurance
MCB59.42-1.96
-3.19%
Metropolitan Bank Holding Corp
INTC24.87-1.22
-4.68%
Intel Corp

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with STRO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then STRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
-10.65%
STRO - ALGS
39%
Loosely correlated
-3.28%
CNSP - ALGS
27%
Poorly correlated
-13.87%
XNCR - ALGS
27%
Poorly correlated
-0.32%
TSHA - ALGS
27%
Poorly correlated
-1.83%
CRNX - ALGS
27%
Poorly correlated
+1.63%
More

SEPSF and

Correlation & Price change

A.I.dvisor tells us that SEPSF and VTYX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SEPSF and VTYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SEPSF
1D Price
Change %
SEPSF100%
N/A
VTYX - SEPSF
29%
Poorly correlated
-3.01%
CLVLF - SEPSF
25%
Poorly correlated
N/A
ALGS - SEPSF
24%
Poorly correlated
-10.65%
BVAXF - SEPSF
21%
Poorly correlated
+2.56%
ALLR - SEPSF
14%
Poorly correlated
+1.44%
More